Jeffrey Prem, MD
Vascular Surgery · North Canton, OHNPI 1235110693
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $22,385 of the $37,026 with a category attached, or 60.5%. Boston Scientific accounts for 78.4% of it on its own, with 19 other manufacturers making up the rest. Among vascular surgery clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $238.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$29K
- Penumbra, Inc.$3K
- W. L. Gore & Associates, Inc.$3K
- Inari Medical, Inc.$764
- Artivion, Inc.$584
- Endologix LLC$145
- plus $607 from 14 others
Across 22 payments — averaging $902.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$20K
What the payments were for
- Consulting fees$22,38560%
- Speaking & faculty fees$3,0008%
- Travel & lodging$4,90813%
- Food & beverage$6,73318%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 86 | $29,037 |
| Penumbra, Inc. | 2 | $3,144 |
| W. L. Gore & Associates, Inc. | 35 | $2,746 |
| Inari Medical, Inc. | 2 | $764 |
| Artivion, Inc. | 6 | $584 |
| Endologix LLC | 1 | $145 |
| Cordis US CORP. | 5 | $125 |
| Medtronic | 2 | $121 |
| Johnson & Johnson(2 entities) | 3 | $63 |
| Silk Road Medical, Inc. | 2 | $48 |
| Surmodics, Inc. | 1 | $45 |
| Vasorum USA Inc. | 1 | $45 |
| Stryker | 1 | $38 |
| Dilon Technologies, Inc. | 2 | $36 |
| Angiodynamics, Inc. | 1 | $18 |
| Mozarc Medical US LLC | 1 | $16 |
| Cardinal Health 200 LLC | 1 | $15 |
| Biocompatibles, Inc. | 1 | $14 |
| EKOS Corporation | 1 | $12 |
| Chiesi USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$13,208
- GENERAL VASCULAR INTERVENTION$3,431
- Indigo System$3,144
- FLOWTRIEVER CATHETER, S$1,446
- GENERAL ATHERECTOMY$689
- GORE TAG Thoracic Branch Endoprosthesis$516
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$367
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$366
- EXCLUDER AAA Endoprosthesis$203
- GORE VIABAHN VBX Balloon Expandable Endo$202
- GORE TAG Conformable Thoracic Endoprosthesis$186
- ENDOCROSS Device$145
- Torus Stent Graft System$145
- VIABAHN VBX Balloon Expandable Endoprosthesis$139
- GORE EXCLUDER AAA Endoprosthesis$139
- EXCLUDER Iliac Branch Endoprosthesis$132
- C3 Delivery System$107
- GENERAL EMBOLICS$105
- Endurant$100
How this compares
$37,026 in reported general payments places this provider in the 90th percentile of 213 vascular surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 90 | $70,664 |
| EliquisApixaban | 71 | $67,216 |
| ClopidogrelClopidogrel Bisulfate | 573 | $5,525 |
| Cilostazol | 182 | $2,212 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 120 | $206 |
| Cephalexin | 93 | $194 |
| Celecoxib | 17 | $128 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $60 |
| Lorazepam | 63 | $34 |
| Prednisone | 15 | $12 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $63 | $70,66490 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 213 vascular surgery providers in Ohio.
Other vascular surgery in North Canton
- Matthew MillerNorth Canton$42K
- Patrick MuckCincinnati$650K
- Sean LydenCleveland$561K
- Brian KuhnCincinnati$184K
- Vikram RaoWilloughby$137K
- Federico ParodiCleveland$78K
- Francis CaputoCleveland$75K
- Matthew RechtCincinnati$73K
- Geoffrey AnswiniCincinnati$65K
- John PigottToledo$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.